Silent assassin: Oncogenic Ras directs epigenetic inactivation of target genes

Science Signaling

Volumn 1, Issue 13, 2008, Pages

  Cheng, Xiaodong ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21;

ARTICLE; CPG ISLAND; DNA METHYLATION; GENE SILENCING; GENETIC EPIGENESIS; PHYSIOLOGY;

CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; ONCOGENE PROTEIN P21(RAS);

EID: 48849083854     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/stke.113pe14     Document Type: Review

References (33)

1. D. Hanahan, R. A. Weinberg, The hallmarks of cancer. Cell 100, 57-70 (2000).
2. C. Gazin, N. Wajapeyee, S. Gobeil, C. M. Virbasius, M. R. Green, An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449, 1073-1077 (2007).
3. M. G. Goll, T. H. Bestor, Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005).
4. A. P. Feinberg, B. Vogelstein, Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92 (1983).
5. S. E. Goelz, B. Vogelstein, S. R. Hamilton, A. P. Feinberg, Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187-190 (1985).
6. A. P. Feinberg, C. W. Gehrke, K. C. Kuo, M. Ehrlich, Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159-1161 (1988).
7. M. Ehrlich, DNA methylation in cancer: Too much, but also too little. Oncogene 21, 5400-5413 (2002).
8. M. S. Cheah, C. D. Wallace, R. M. Hoffman, Hypomethylation of DNA in human cancer cells: A site-specific change in the c-myc oncogene. J. Natl. Cancer Inst. 73, 1057-1065 (1984).
9. M. Nishigaki, K. Aoyagi, I. Danjoh, M. Fukaya, K. Yanagihara, H. Sakamoto, T. Yoshida, H. Sasaki, Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 65, 2115-2124 (2005).
10. R. A. Alcock, S. Dey, D. Chendil, M. S. Inayat, M. Mohiuddin, G. Hartman, L. K. Chatfield, V. S. Gallicchio, M. M. Ahmed, Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivityin K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene 21, 7883-7890 (2002).
11. H. Cui, M. Cruz-Correa, F. M. Giardiello, D. F. Hutcheon, D. R. Kafonek, S. Brandenburg, Y. Wu,X. He, N. R. Powe, A. P. Feinberg, Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 299, 1753-1755 (2003).
12. A. Kaneda, A. P. Feinberg, Loss of imprinting of IGF2: A common epigenetic modifier of intestinal tumor risk. Cancer Res. 65, 11236-11240 (2005).
13. A. Eden, F. Gaudet, A. Waghmare, R. Jaenisch, Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003).
14. F. Gaudet, J. G. Hodgson, A. Eden, L. Jackson- Grusby, J. Dausman, J.W. Gray, H. Leonhardt, R. Jaenisch, Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492 (2003).
15. G.-L. Xu, T. H. Bestor, D. Bourc'his, C.-L. Hsieh, N. Tommerup, M. Bugge, M. Hulten, X. Qu, J. J. Russo, E. Viegas-Pequignot, Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187-191 (1999).
16. J. L. Bos, Ras oncogenes in human cancer: A review. Cancer Res. 49, 4682-4689 (1989).
17. J. Downward, Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22 (2003).
18. R. G. Fenton, J. A. Hixon, P. W. Wright, A. D. Brooks, T. J. Sayers, Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res. 58, 3391-3400 (1998).
19. J. Peli, M. Schroter, C. Rudaz, M. Hahne, C. Meyer, E. Reichmann, J. Tschopp, Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J. 18, 1824-1831 (1999).
20. R. J. Guan, Y. Fu, P. R. Holt, A. B. Pardee, Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology 116, 1063-1071 (1999).
21. S. Contente, K. Kenyon, P. Sriraman, S. Subramanyan, R. M. Friedman, Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene. Mol. Cell. Biochem. 194, 79-91 (1999).
22. K. Pruitt, A. S. Ulkü, K. Frantz, R. J. Rojas, V. M. Muniz-Medina, V. M. Rangnekar, C. J. Der, J. M. Shields, RAS mediated loss of the pro-apoptotic response protein par-4 is mediated by DNA hypermethylation through RAF-independent and RAF-dependent signaling cascades in epithelial cells. J. Biol. Chem. 280, 23363-23370 (2005).
23. J. M. Shields, H. Mehta, K. Pruitt, C. J. Der, Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol. Cell. Biol. 22, 2304-2317 (2002).
24. F. C. Mei, T.W. Young, J. Liu, X. Cheng, RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J. 20, 497-499 (2006).
25. A. R. MacLeod, J. Rouleau, M. Szyf, Regulation of DNA methylation by the Ras signaling pathway. J. Biol. Chem. 270, 11327-11337 (1995).
26. J. M. Ordway, K. Williams, T. Curran, Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 23, 3737-3748 (2004).
27. L. Di Croce, V. A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F. Lo Coco, T. Kouzarides, C. Nervi, S. Minucci, P. G. Pelicci, Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082 (2002).
28. C. Brenner, R. Deplus, C. Didelot, A. Loriot, E. Vire, C. De Smet, A. Gutierrez, D. Danovi, D. Bernard, T. Boon, P. G. Pelicci, B. Amati, T. Kouzarides, Y. de Launoit, L. Di Croce, F. Fuks, Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24, 336-346 (2005).
29. E. Viré, C. Brenner, R. Deplus, L. Blanchon, M. Fraga, C. Didelot, L. Morey, A. Van Eynde, D. Bernard, J.-M. Vanderwinden, M. Bollen, M. Esteller, L. Di Croce, Y. de Launoit, F. Fuks, The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (2006).
30. Y. Schlesinger, R. Straussman, I. Keshet, S. Farkash, M. Hecht, J. Zimmerman, E. Eden, Z. Yakhini, E. Ben Shushan, B. E. Reubinoff, Y. Bergman, I. Simon, H. Cedar, Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39, 232-236 (2007).
31. M. Serrano, A.W. Lin, M. E. McCurrach, D. Beach, S. W. Lowe, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
32. A. Rangarajan, S. J. Hong, A. Gifford, R. A.Weinberg, Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171-183 (2004).
33. X. Cheng, Silent assassin: Oncogenic Ras directs epigenetic inactivation of target genes. Sci. Signal. 1, pe14 (2008).